The changing molecular epidemiology of HIV-1 in Liangshan prefecture, China, in 2021–2023

IntroductionLiangshan Prefecture is one of the areas in China most severely affected by human immunodeficiency virus (HIV), but little is known about the molecular epidemiology of HIV-1 in this area. We aimed to analyze the distribution of HIV-1 genetic variants in Liangshan Prefecture in recent yea...

Full description

Saved in:
Bibliographic Details
Main Authors: Rong Pei, Ling Su, Chunnong Jike, Gang Yu, Ju Wang, Lin Xiao, Yubing Wang, Maogang Shen, Chang Zhou, Jiayi Liao, Yulian Zhang, Yifei Zheng, Joris Hemelaar
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2025.1520864/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849774238736580608
author Rong Pei
Rong Pei
Ling Su
Chunnong Jike
Gang Yu
Ju Wang
Lin Xiao
Yubing Wang
Maogang Shen
Chang Zhou
Jiayi Liao
Yulian Zhang
Yifei Zheng
Joris Hemelaar
author_facet Rong Pei
Rong Pei
Ling Su
Chunnong Jike
Gang Yu
Ju Wang
Lin Xiao
Yubing Wang
Maogang Shen
Chang Zhou
Jiayi Liao
Yulian Zhang
Yifei Zheng
Joris Hemelaar
author_sort Rong Pei
collection DOAJ
description IntroductionLiangshan Prefecture is one of the areas in China most severely affected by human immunodeficiency virus (HIV), but little is known about the molecular epidemiology of HIV-1 in this area. We aimed to analyze the distribution of HIV-1 genetic variants in Liangshan Prefecture in recent years.Methods8,523 blood samples were collected from people living with HIV with treatment failure and newly diagnosed individuals in all 17 counties and cities in Liangshan Prefecture between 2021 and 2023.ResultsThe majority of study participants were male (66%), farmers (78%) and illiterate (53%). The main HIV-1 transmission routes were heterosexual contact (57%) and injecting drug use (27%). Among the 6,298 successfully obtained pol sequences the following HIV-1 variants were identified: CRF07_BC (93.9%), CRF08_BC (3.3%), CRF01_AE (1.4%), URFs (0.9%), CRF105_0108 (0.1%), CRF55_01B (0.1%), subtype B (0.1%), subtype C (0.1%), CRF88_BC (0.1%), CRF83_cpx (0.1%), CRF85_BC (0.03%), CRF67_01B (0.02%), CRF77_cpx (0.02%), and subtype A (0.02%). During the study period, the proportion of CRF07_BC gradually decreased, while other HIV-1 variants increased, a shift seen across all counties in Liangshan Prefecture. Newly diagnosed patients mainly acquired HIV through heterosexual transmission (86.7%), had a lower proportion of CRF07_BC (90.9%) and higher proportion of other HIV-1 variants, compared to treatment failure patients.ConclusionFuture prevention and control policies need to take these changes into account.
format Article
id doaj-art-376972bb9c164fd794413a28fdc48080
institution DOAJ
issn 1664-302X
language English
publishDate 2025-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj-art-376972bb9c164fd794413a28fdc480802025-08-20T03:01:47ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2025-03-011610.3389/fmicb.2025.15208641520864The changing molecular epidemiology of HIV-1 in Liangshan prefecture, China, in 2021–2023Rong Pei0Rong Pei1Ling Su2Chunnong Jike3Gang Yu4Ju Wang5Lin Xiao6Yubing Wang7Maogang Shen8Chang Zhou9Jiayi Liao10Yulian Zhang11Yifei Zheng12Joris Hemelaar13Nuffield Department of Population Health, Infectious Disease Epidemiology Unit, National Perinatal Epidemiology Unit, University of Oxford, Oxford, United KingdomSchool of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaSichuan Provincial Center for Disease Control and Prevention, Center for AIDS/STD Control and Prevention, Chengdu, ChinaLiangshan Prefecture Centre for Disease Control and Prevention, Xichang, Xichang, ChinaLiangshan Prefecture Centre for Disease Control and Prevention, Xichang, Xichang, ChinaLiangshan Prefecture Centre for Disease Control and Prevention, Xichang, Xichang, ChinaLiangshan Prefecture Centre for Disease Control and Prevention, Xichang, Xichang, ChinaLiangshan Prefecture Centre for Disease Control and Prevention, Xichang, Xichang, ChinaLiangshan Prefecture Centre for Disease Control and Prevention, Xichang, Xichang, ChinaSichuan Provincial Center for Disease Control and Prevention, Center for AIDS/STD Control and Prevention, Chengdu, ChinaSchool of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaSchool of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaSchool of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaNuffield Department of Population Health, Infectious Disease Epidemiology Unit, National Perinatal Epidemiology Unit, University of Oxford, Oxford, United KingdomIntroductionLiangshan Prefecture is one of the areas in China most severely affected by human immunodeficiency virus (HIV), but little is known about the molecular epidemiology of HIV-1 in this area. We aimed to analyze the distribution of HIV-1 genetic variants in Liangshan Prefecture in recent years.Methods8,523 blood samples were collected from people living with HIV with treatment failure and newly diagnosed individuals in all 17 counties and cities in Liangshan Prefecture between 2021 and 2023.ResultsThe majority of study participants were male (66%), farmers (78%) and illiterate (53%). The main HIV-1 transmission routes were heterosexual contact (57%) and injecting drug use (27%). Among the 6,298 successfully obtained pol sequences the following HIV-1 variants were identified: CRF07_BC (93.9%), CRF08_BC (3.3%), CRF01_AE (1.4%), URFs (0.9%), CRF105_0108 (0.1%), CRF55_01B (0.1%), subtype B (0.1%), subtype C (0.1%), CRF88_BC (0.1%), CRF83_cpx (0.1%), CRF85_BC (0.03%), CRF67_01B (0.02%), CRF77_cpx (0.02%), and subtype A (0.02%). During the study period, the proportion of CRF07_BC gradually decreased, while other HIV-1 variants increased, a shift seen across all counties in Liangshan Prefecture. Newly diagnosed patients mainly acquired HIV through heterosexual transmission (86.7%), had a lower proportion of CRF07_BC (90.9%) and higher proportion of other HIV-1 variants, compared to treatment failure patients.ConclusionFuture prevention and control policies need to take these changes into account.https://www.frontiersin.org/articles/10.3389/fmicb.2025.1520864/fullHIV-1molecular epidemiologycirculating recombinant formssubtypeunique recombinant forms
spellingShingle Rong Pei
Rong Pei
Ling Su
Chunnong Jike
Gang Yu
Ju Wang
Lin Xiao
Yubing Wang
Maogang Shen
Chang Zhou
Jiayi Liao
Yulian Zhang
Yifei Zheng
Joris Hemelaar
The changing molecular epidemiology of HIV-1 in Liangshan prefecture, China, in 2021–2023
Frontiers in Microbiology
HIV-1
molecular epidemiology
circulating recombinant forms
subtype
unique recombinant forms
title The changing molecular epidemiology of HIV-1 in Liangshan prefecture, China, in 2021–2023
title_full The changing molecular epidemiology of HIV-1 in Liangshan prefecture, China, in 2021–2023
title_fullStr The changing molecular epidemiology of HIV-1 in Liangshan prefecture, China, in 2021–2023
title_full_unstemmed The changing molecular epidemiology of HIV-1 in Liangshan prefecture, China, in 2021–2023
title_short The changing molecular epidemiology of HIV-1 in Liangshan prefecture, China, in 2021–2023
title_sort changing molecular epidemiology of hiv 1 in liangshan prefecture china in 2021 2023
topic HIV-1
molecular epidemiology
circulating recombinant forms
subtype
unique recombinant forms
url https://www.frontiersin.org/articles/10.3389/fmicb.2025.1520864/full
work_keys_str_mv AT rongpei thechangingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT rongpei thechangingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT lingsu thechangingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT chunnongjike thechangingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT gangyu thechangingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT juwang thechangingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT linxiao thechangingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT yubingwang thechangingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT maogangshen thechangingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT changzhou thechangingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT jiayiliao thechangingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT yulianzhang thechangingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT yifeizheng thechangingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT jorishemelaar thechangingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT rongpei changingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT rongpei changingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT lingsu changingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT chunnongjike changingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT gangyu changingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT juwang changingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT linxiao changingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT yubingwang changingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT maogangshen changingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT changzhou changingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT jiayiliao changingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT yulianzhang changingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT yifeizheng changingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023
AT jorishemelaar changingmolecularepidemiologyofhiv1inliangshanprefecturechinain20212023